Institutional Ownership Phathom Pharmaceuticals, Inc. (PHAT)
This table provides information about the institutional ownership of Phathom Pharmaceuticals, Inc. (PHAT). We have compiled data on the 144 institutions that hold shares in the stock, with a total of 73.6 Million shares, which have been reported (via 13F filing form) to have a value of $560 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
10,109,279
shares
|
$76.9 Million
9.84% of portfolio
|
Q2 2023
Added 20.25%
|
|
|
Medicxi Ventures Management (Jersey) LTD
|
Oct 15, 2024 Q3 2024 |
7,464,572
shares
|
$56.8 Million
28.04% of portfolio
|
Q1 2024
Added 98.48%
|
|
|
Jennison Associates LLC
|
Nov 08, 2024 Q3 2024 |
5,866,389
shares
|
$44.6 Million
0.07% of portfolio
|
Q3 2024
Added 112.74%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
4,096,762
shares
|
$31.2 Million
0.01% of portfolio
|
Q3 2024
Added 30.33%
|
|
|
Carlyle Group Inc.
Washington, DC |
Nov 08, 2024 Q3 2024 |
3,496,808
shares
|
$26.6 Million
9.52% of portfolio
|
Q2 2023
Added 19.14%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,926,373
shares
|
$22.3 Million
0.0% of portfolio
|
Q2 2024
Added 6.59%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
2,696,323
shares
|
$20.5 Million
0.0% of portfolio
|
Q3 2024
Added 21.91%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
2,581,388
shares
|
$19.6 Million
0.08% of portfolio
|
Q3 2024
Added 14.99%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
2,573,412
shares
|
$19.6 Million
0.42% of portfolio
|
Q3 2024
Added 227.41%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Nov 14, 2024 Q3 2024 |
1,960,169
shares
|
$14.9 Million
2.71% of portfolio
|
Q4 2023
Added 53.55%
|
|
|
Avidity Partners Management LP
Dallas, TX |
Nov 14, 2024 Q3 2024 |
1,804,493
shares
|
$13.7 Million
2.0% of portfolio
|
Q3 2024
Added 11.39%
|
|
|
Portolan Capital Management, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,699,918
shares
|
$12.9 Million
2.44% of portfolio
|
Q3 2024
Added 50.42%
|
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,622,883
shares
|
$12.4 Million
0.37% of portfolio
|
Q3 2024
Added 10.23%
|
|
|
Checkpoint Capital L.P.
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,504,307
shares
|
$11.4 Million
13.49% of portfolio
|
Q3 2024
Added 71.92%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
1,449,073
shares
|
$11 Million
0.62% of portfolio
|
Q3 2024
New holding
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
1,435,106
shares
|
$10.9 Million
5.34% of portfolio
|
Q1 2022
Added 19.28%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
1,403,638
shares
|
$10.7 Million
0.06% of portfolio
|
Q3 2024
New holding
|
|
|
Decheng Capital LLC
Menlo Park, CA |
Nov 14, 2024 Q3 2024 |
1,250,000
shares
|
$9.51 Million
5.35% of portfolio
|
Q3 2024
Added 47.06%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 07, 2024 Q3 2024 |
1,126,083
shares
|
$8.57 Million
0.17% of portfolio
|
Q3 2024
Added 87.54%
|
|
|
Catalys Pacific, LLC
Tokyo, M0 |
Nov 12, 2024 Q3 2024 |
1,122,572
shares
|
$8.54 Million
16.19% of portfolio
|
Q3 2024
Added 55.49%
|
|
|
683 Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,010,000
shares
|
$7.69 Million
1.66% of portfolio
|
Q3 2024
Reduced 27.86%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
922,788
shares
|
$7.02 Million
0.0% of portfolio
|
Q3 2024
Added 17.52%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
874,590
shares
|
$6.66 Million
5.65% of portfolio
|
Q3 2024
Added 47.41%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
869,927
shares
|
$6.62 Million
9.12% of portfolio
|
Q1 2024
Added 96.35%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
862,918
shares
|
$6.57 Million
0.0% of portfolio
|
Q3 2024
Added 7.06%
|